首页 > 最新文献

Journal of Thyroid Research最新文献

英文 中文
Utility of Shear Wave Elastography for Diagnosing Chronic Autoimmune Thyroiditis. 剪切波弹性成像诊断慢性自身免疫性甲状腺炎的应用。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2015-01-01 Epub Date: 2015-07-16 DOI: 10.1155/2015/164548
Takahiro Fukuhara, Eriko Matsuda, Shoichiro Izawa, Kazunori Fujiwara, Hiroya Kitano

The aims of this study were to evaluate the utility of shear wave elastography (SWE) using acoustic radiation force impulse (ARFI) for diagnosing chronic autoimmune thyroiditis (CAT) and to verify the effect of fibrotic thyroid tissue on shear wave velocity (SWV). The subjects were 229 patients with 253 normal thyroid lobes (controls) and 150 CAT lobes. The SWV for CAT (2.47 ± 0.57 m/s) was significantly higher than that for controls (1.59 ± 0.41 m/s) (P < 0.001). The area under the receiver operating characteristics (ROC) curve for CAT was 0.899, and the SWV cut-off value was 1.96 m/s. The sensitivity, specificity, and diagnostic accuracy were 87.4%, 78.7%, and 85.1%, respectively. Levels of anti-thyroperoxidase antibodies and thyroid isthmus thickness were correlated with tissue stiffness in CAT. However, there was no correlation between levels of anti-thyroglobulin antibodies and tissue stiffness. Quantitative SWE is useful for diagnosing CAT, and it is possible that SWE can be used to evaluate the degree of fibrosis in patients with CAT.

本研究的目的是评估使用声辐射力脉冲(ARFI)诊断慢性自身免疫性甲状腺炎(CAT)的剪切波弹性成像(SWE)的效用,并验证纤维化甲状腺组织对剪切波速度(SWV)的影响。229例正常甲状腺叶(对照)253例,CAT叶150例。CAT组的SWV(2.47±0.57 m/s)显著高于对照组(1.59±0.41 m/s) (P < 0.001)。CAT受试者工作特征(ROC)曲线下面积为0.899,SWV截止值为1.96 m/s。敏感性、特异性和诊断准确率分别为87.4%、78.7%和85.1%。抗甲状腺过氧化物酶抗体水平和甲状腺峡部厚度与CAT的组织僵硬度相关。然而,抗甲状腺球蛋白抗体水平与组织硬度之间没有相关性。定量SWE对CAT的诊断是有用的,并且有可能用于评估CAT患者的纤维化程度。
{"title":"Utility of Shear Wave Elastography for Diagnosing Chronic Autoimmune Thyroiditis.","authors":"Takahiro Fukuhara,&nbsp;Eriko Matsuda,&nbsp;Shoichiro Izawa,&nbsp;Kazunori Fujiwara,&nbsp;Hiroya Kitano","doi":"10.1155/2015/164548","DOIUrl":"https://doi.org/10.1155/2015/164548","url":null,"abstract":"<p><p>The aims of this study were to evaluate the utility of shear wave elastography (SWE) using acoustic radiation force impulse (ARFI) for diagnosing chronic autoimmune thyroiditis (CAT) and to verify the effect of fibrotic thyroid tissue on shear wave velocity (SWV). The subjects were 229 patients with 253 normal thyroid lobes (controls) and 150 CAT lobes. The SWV for CAT (2.47 ± 0.57 m/s) was significantly higher than that for controls (1.59 ± 0.41 m/s) (P < 0.001). The area under the receiver operating characteristics (ROC) curve for CAT was 0.899, and the SWV cut-off value was 1.96 m/s. The sensitivity, specificity, and diagnostic accuracy were 87.4%, 78.7%, and 85.1%, respectively. Levels of anti-thyroperoxidase antibodies and thyroid isthmus thickness were correlated with tissue stiffness in CAT. However, there was no correlation between levels of anti-thyroglobulin antibodies and tissue stiffness. Quantitative SWE is useful for diagnosing CAT, and it is possible that SWE can be used to evaluate the degree of fibrosis in patients with CAT. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2015 ","pages":"164548"},"PeriodicalIF":2.1,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/164548","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33908721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 41
Tumor Growth Mitigating Effects of Valproic Acid in Systemic Malignancies. 丙戊酸在系统性恶性肿瘤中的抑制肿瘤生长作用。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2015-01-01 Epub Date: 2015-07-28 DOI: 10.1155/2015/540183
Shailendra Kapoor
Recent data suggests that valproic acid (VPCA) also attenuates and limits tumor growth in a number of systemic malignancies [1]. For instance, VPCA has a suppressive effect on tumor growth in renal malignancies. Oertl et al. have recently shown that VPCA mediates this role in part by altering the expression of beta1 integrins in tumor cells [2]. VPCA also mediates this role in part by upregulating BAX expression. These changes have recently been confirmed in Caki-1 and KTC-26 cell lines. In addition, VPCA accentuates the expression of ULBP1 and ULBP2. Jones et al. have recently demonstrated that, at the same time, VPCA accentuates p21 expression [3]. Recent data also suggests that IFN-alpha accentuates the cytotoxic effects of VPCA. Cyclin B and cyclin D3 levels are also modulated by VPCA [4]. Yang et al. have recently demonstrated that VPCA also accentuates the cytotoxicity of NK cells against renal cancer cells [5]. In addition, VPCA also affects tumor cell adhesiveness thereby further attenuating tumor expansion in renal carcinomas [6]. Similarly, VPCA has an inhibitory effect on tumor growth in gastric malignancies. VPCA has a positive impact on acetyl-α-tubulin levels. It also mediates this role in part by attenuating c-Myc expression. Bcl-2 expression is downregulated concurrently. As a result, tumor cell apoptosis is markedly augmented. Zhao et al. have recently demonstrated that this is accompanied by accentuation of p21 (Waf/cip1) expression [7]. These changes have recently been confirmed in BGC-823, OCUM-2MD3, HGC-27, and SGC-7901 cell lines. In addition, VPCA has a negative impact on cyclin A as well as cyclin D1 expression. At the same time, tumor cell proliferation is markedly attenuated [8]. This is accompanied by accentuation of acetyl-histone H3 levels. G1 phase arrest is typically seen. In addition, Yagi et al. have recently demonstrated that survivin expression is significantly downregulated [9]. Mad1 expression is upregulated concurrently. p27 expression is also accentuated simultaneously. Besides the above-mentioned changes, VPCA also augments and enhances caspase 9 and caspase 3 activation thereby further abrogating tumor growth in gastric carcinomas. As is obvious from the above discussion, VPCA exhibits potent tumor growth mitigating effects. Hopefully, the coming few years will see an increase in the utilization of VPCA as an antineoplastic agent.
{"title":"Tumor Growth Mitigating Effects of Valproic Acid in Systemic Malignancies.","authors":"Shailendra Kapoor","doi":"10.1155/2015/540183","DOIUrl":"https://doi.org/10.1155/2015/540183","url":null,"abstract":"Recent data suggests that valproic acid (VPCA) also attenuates and limits tumor growth in a number of systemic malignancies [1]. \u0000 \u0000For instance, VPCA has a suppressive effect on tumor growth in renal malignancies. Oertl et al. have recently shown that VPCA mediates this role in part by altering the expression of beta1 integrins in tumor cells [2]. VPCA also mediates this role in part by upregulating BAX expression. These changes have recently been confirmed in Caki-1 and KTC-26 cell lines. In addition, VPCA accentuates the expression of ULBP1 and ULBP2. Jones et al. have recently demonstrated that, at the same time, VPCA accentuates p21 expression [3]. Recent data also suggests that IFN-alpha accentuates the cytotoxic effects of VPCA. Cyclin B and cyclin D3 levels are also modulated by VPCA [4]. Yang et al. have recently demonstrated that VPCA also accentuates the cytotoxicity of NK cells against renal cancer cells [5]. In addition, VPCA also affects tumor cell adhesiveness thereby further attenuating tumor expansion in renal carcinomas [6]. \u0000 \u0000Similarly, VPCA has an inhibitory effect on tumor growth in gastric malignancies. VPCA has a positive impact on acetyl-α-tubulin levels. It also mediates this role in part by attenuating c-Myc expression. Bcl-2 expression is downregulated concurrently. As a result, tumor cell apoptosis is markedly augmented. Zhao et al. have recently demonstrated that this is accompanied by accentuation of p21 (Waf/cip1) expression [7]. These changes have recently been confirmed in BGC-823, OCUM-2MD3, HGC-27, and SGC-7901 cell lines. In addition, VPCA has a negative impact on cyclin A as well as cyclin D1 expression. At the same time, tumor cell proliferation is markedly attenuated [8]. This is accompanied by accentuation of acetyl-histone H3 levels. G1 phase arrest is typically seen. In addition, Yagi et al. have recently demonstrated that survivin expression is significantly downregulated [9]. Mad1 expression is upregulated concurrently. p27 expression is also accentuated simultaneously. Besides the above-mentioned changes, VPCA also augments and enhances caspase 9 and caspase 3 activation thereby further abrogating tumor growth in gastric carcinomas. \u0000 \u0000As is obvious from the above discussion, VPCA exhibits potent tumor growth mitigating effects. Hopefully, the coming few years will see an increase in the utilization of VPCA as an antineoplastic agent.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2015 ","pages":"540183"},"PeriodicalIF":2.1,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/540183","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34004114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anti-thyroid peroxidase antibody in vitiligo: a prevalence study. 抗甲状腺过氧化物酶抗体在白癜风中的流行研究。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2015-01-01 Epub Date: 2015-01-11 DOI: 10.1155/2015/192736
R Dash, A Mohapatra, B S Manjunathswamy

Aim. The aim of the study was to study the relation of vitiligo with demographic data like age, sex, and duration and determine the prevalence of thyroid autoimmunity in vitiligo patients. Materials and Methods. This study was a cross sectional study consisting of 100 patients clinically diagnosed (old and new) as having vitiligo irrespective of age or sex. Patients with known thyroid disease on supplementation therapy, or who had undergone thyroid surgery, those on antithyroid medication, patients with other causes of leukoderma, and cases who do not provide informed consent were excluded from the study. Serum TSH and anti-TPO antibodies were measured in all the patients. Results. The prevalence of anti-TPO antibody positivity was found to be 28%. Conclusion. According to our study, none of our vitiligo patients had symptoms or signs of thyroid disease at the time of presentation but, on biochemical evaluation, anti-TPO antibodies were found in a considerable number of patients. Hence, we recommend screening of these patients with thyroid antibodies.

的目标。本研究的目的是研究白癜风与年龄、性别、病程等人口统计学数据的关系,并确定白癜风患者甲状腺自身免疫的患病率。材料与方法。这项研究是一项横断面研究,包括100名临床诊断为白癜风的患者(新老),无论年龄或性别。已知正在接受补充治疗的甲状腺疾病患者、接受过甲状腺手术的患者、接受抗甲状腺药物治疗的患者、其他原因的白癜风患者以及未提供知情同意的患者被排除在研究之外。检测患者血清TSH和抗tpo抗体。结果。抗tpo抗体阳性率为28%。结论。根据我们的研究,我们的白癜风患者在出现时都没有甲状腺疾病的症状或体征,但在生化评估中,在相当多的患者中发现了抗tpo抗体。因此,我们建议对这些患者进行甲状腺抗体筛查。
{"title":"Anti-thyroid peroxidase antibody in vitiligo: a prevalence study.","authors":"R Dash,&nbsp;A Mohapatra,&nbsp;B S Manjunathswamy","doi":"10.1155/2015/192736","DOIUrl":"https://doi.org/10.1155/2015/192736","url":null,"abstract":"<p><p>Aim. The aim of the study was to study the relation of vitiligo with demographic data like age, sex, and duration and determine the prevalence of thyroid autoimmunity in vitiligo patients. Materials and Methods. This study was a cross sectional study consisting of 100 patients clinically diagnosed (old and new) as having vitiligo irrespective of age or sex. Patients with known thyroid disease on supplementation therapy, or who had undergone thyroid surgery, those on antithyroid medication, patients with other causes of leukoderma, and cases who do not provide informed consent were excluded from the study. Serum TSH and anti-TPO antibodies were measured in all the patients. Results. The prevalence of anti-TPO antibody positivity was found to be 28%. Conclusion. According to our study, none of our vitiligo patients had symptoms or signs of thyroid disease at the time of presentation but, on biochemical evaluation, anti-TPO antibodies were found in a considerable number of patients. Hence, we recommend screening of these patients with thyroid antibodies. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2015 ","pages":"192736"},"PeriodicalIF":2.1,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/192736","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33030116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Correlation of fine needle aspiration cytology findings with thyroid function test in cases of lymphocytic thyroiditis. 淋巴细胞性甲状腺炎细针穿刺细胞学检查与甲状腺功能检查的相关性。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2014-01-01 Epub Date: 2014-04-06 DOI: 10.1155/2014/430510
Neelam Sood, Jitendra Singh Nigam

Background. Chronic lymphocytic thyroiditis is the second most common thyroid lesion diagnosed on FNAC after goiter. FNAC is reliable tool in the diagnosis of thyroid lesion. Objective. To correlate FNAC cytologic findings with TFT in the lymphocytic thyroiditis. Methods. 175 patients with thyroid swellings were referred for FNAC as well as TFT during 2011-2013. Fine needle aspiration cytology was performed using non-aspiration or aspiration techniques and TFT performed on Beckman culter access 2. Results. Lymphoid infiltrate was seen in 55 cases. The commonest age group of lymphocytic thyroiditis was 21-30 years with male : female ratio being 1 : 10. Anti-TPO and TSH were elevated in 96.16% (25/26) of cases with grade 3 lymphoid infiltrate, 94.12% (16/17) of cases with grade 2, and 91.67% (11/12) of cases with 1 grade. Increased anti-TPO with raised TSH without any lymphoid infiltrate was seen in 5 cases and 5 cases showed only raised TSH without raised anti-TPO and without any lymphoid infiltrate. We observed that grade 3 lymphocytic infiltration has correlation with anti-TPO and TSH together or TSH alone but not with anti-TPO alone. We also observed that anti-TPO and TSH together are significant even if no lymphocytic infiltration is present. Conclusion. Grade 3 lymphocytic infiltration has statistical correlation with anti-TPO and TSH together or TSH alone but not with anti-TPO alone. Anti TPO was adjunct to TSH in grade 3. The presence of Hurthle cell change, giant cells, and granulomas has no statistical correlation with lymphocytic thyroiditis.

背景。慢性淋巴细胞性甲状腺炎是FNAC诊断的第二大常见甲状腺病变,仅次于甲状腺肿。FNAC是诊断甲状腺病变的可靠工具。目标。目的探讨淋巴细胞性甲状腺炎FNAC细胞学表现与TFT的相关性。方法:2011-2013年,175例甲状腺肿大患者行FNAC和TFT检查。采用非抽吸或抽吸技术进行细针抽吸细胞学检查,在Beckman culter通路2上进行TFT检查。结果。淋巴样浸润55例。淋巴细胞性甲状腺炎最常见的年龄组为21 ~ 30岁,男女比例为1:10。淋巴组织浸润3级96.16%(25/26)、2级94.12%(16/17)、1级91.67%(11/12)的患者抗tpo和TSH升高。5例抗tpo升高,TSH升高,无淋巴浸润;5例仅TSH升高,抗tpo升高,无淋巴浸润。我们观察到3级淋巴细胞浸润与抗tpo和TSH联合或单独TSH相关,而与抗tpo无关。我们还观察到,即使没有淋巴细胞浸润,抗tpo和TSH的作用也很显著。结论。3级淋巴细胞浸润与抗tpo和TSH联合或单用TSH有统计学相关性,与抗tpo单用无统计学相关性。抗TPO在3级时辅助TSH。Hurthle细胞改变、巨细胞、肉芽肿与淋巴细胞性甲状腺炎无统计学相关性。
{"title":"Correlation of fine needle aspiration cytology findings with thyroid function test in cases of lymphocytic thyroiditis.","authors":"Neelam Sood,&nbsp;Jitendra Singh Nigam","doi":"10.1155/2014/430510","DOIUrl":"https://doi.org/10.1155/2014/430510","url":null,"abstract":"<p><p>Background. Chronic lymphocytic thyroiditis is the second most common thyroid lesion diagnosed on FNAC after goiter. FNAC is reliable tool in the diagnosis of thyroid lesion. Objective. To correlate FNAC cytologic findings with TFT in the lymphocytic thyroiditis. Methods. 175 patients with thyroid swellings were referred for FNAC as well as TFT during 2011-2013. Fine needle aspiration cytology was performed using non-aspiration or aspiration techniques and TFT performed on Beckman culter access 2. Results. Lymphoid infiltrate was seen in 55 cases. The commonest age group of lymphocytic thyroiditis was 21-30 years with male : female ratio being 1 : 10. Anti-TPO and TSH were elevated in 96.16% (25/26) of cases with grade 3 lymphoid infiltrate, 94.12% (16/17) of cases with grade 2, and 91.67% (11/12) of cases with 1 grade. Increased anti-TPO with raised TSH without any lymphoid infiltrate was seen in 5 cases and 5 cases showed only raised TSH without raised anti-TPO and without any lymphoid infiltrate. We observed that grade 3 lymphocytic infiltration has correlation with anti-TPO and TSH together or TSH alone but not with anti-TPO alone. We also observed that anti-TPO and TSH together are significant even if no lymphocytic infiltration is present. Conclusion. Grade 3 lymphocytic infiltration has statistical correlation with anti-TPO and TSH together or TSH alone but not with anti-TPO alone. Anti TPO was adjunct to TSH in grade 3. The presence of Hurthle cell change, giant cells, and granulomas has no statistical correlation with lymphocytic thyroiditis. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2014 ","pages":"430510"},"PeriodicalIF":2.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/430510","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32325511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Differential profile of ultrasound findings associated with malignancy in mixed and solid thyroid nodules in an elderly female population. 老年女性混合甲状腺结节和实性甲状腺结节的超声表现与恶性肿瘤的差异分析。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2014-01-01 Epub Date: 2014-06-23 DOI: 10.1155/2014/761653
María Inés Vera, Tomás Meroño, María Agustina Urrutia, Carina Parisi, Yanina Morosan, Melanie Rosmarin, Marta Schnitman, Fernando Brites, Silvio Grisendi, María Sol Serrano, Wilfredo Luciani, Leonardo Serrano, Carlos Zuk, Guillermo De Barrio, Claudia Cejas, María Cristina Faingold, Gabriela Brenta

Objective. Ultrasonographic characteristics are associated with thyroid malignancy. Our aim was to compare the diagnostic value of ultrasound features in the detection of thyroid malignancy in both solid and mixed nodules. Methods. We prospectively studied female patients (≥50 years) referred to ultrasound-guided fine needle aspiration biopsy. Ultrasound features considered suspicious were hypoechogenicity, microcalcifications, irregular margins, high anteroposterior (AP)/axial-ratio, and absent halo. Associations were separately assessed in mixed and solid nodules. Results. In a group of 504 elderly female patients (age = 69 ± 8 years), the frequency of malignant cytology was 6%. Thirty-one percent of nodules were mixed and 60% were solid. The rate of malignant cytology was similar for mixed and solid nodules (7.4 versus 5.8%, P: 0.56). While in mixed nodules none of the ultrasound characteristics were associated with malignant cytology, in solid nodules irregular margins and microcalcifications were significant (all P < 0.05). The combination of irregular margins and/or microcalcifications significantly increased the association with malignant cytology only in solid nodules (OR: 2.76 (95% CI: 1.25-6.10), P: 0.012). Conclusions. Ultrasound features were of poor diagnostic value in mixed nodules, which harbored malignant lesions as often as solid nodules. Our findings challenge the recommended minimal size for ultrasound-guided fine needle aspiration biopsy in mixed nodules.

目标。超声特征与甲状腺恶性肿瘤有关。我们的目的是比较超声特征在检测甲状腺恶性肿瘤的固体和混合结节的诊断价值。方法。我们前瞻性研究了超声引导下细针穿刺活检的女性患者(≥50岁)。可疑的超声特征为低回声、微钙化、边缘不规则、高正轴比和无晕。在混合性和实性结节中分别评估相关性。结果。504例老年女性患者(年龄= 69±8岁),恶性细胞学检出率为6%。31%为混合性结节,60%为实性结节。混合性结节和实性结节的恶性细胞学发生率相似(7.4%对5.8%,P: 0.56)。在混合性结节中,超声特征与恶性细胞学无关,而在实性结节中,边缘不规则和微钙化显著(P < 0.05)。不规则边缘和/或微钙化的结合仅在实性结节中显著增加了恶性细胞学的相关性(or: 2.76 (95% CI: 1.25-6.10), P: 0.012)。结论。超声特征对混合性结节的诊断价值较差,混合性结节与实性结节一样常伴有恶性病变。我们的研究结果挑战了超声引导下对混合性结节进行细针穿刺活检时推荐的最小尺寸。
{"title":"Differential profile of ultrasound findings associated with malignancy in mixed and solid thyroid nodules in an elderly female population.","authors":"María Inés Vera,&nbsp;Tomás Meroño,&nbsp;María Agustina Urrutia,&nbsp;Carina Parisi,&nbsp;Yanina Morosan,&nbsp;Melanie Rosmarin,&nbsp;Marta Schnitman,&nbsp;Fernando Brites,&nbsp;Silvio Grisendi,&nbsp;María Sol Serrano,&nbsp;Wilfredo Luciani,&nbsp;Leonardo Serrano,&nbsp;Carlos Zuk,&nbsp;Guillermo De Barrio,&nbsp;Claudia Cejas,&nbsp;María Cristina Faingold,&nbsp;Gabriela Brenta","doi":"10.1155/2014/761653","DOIUrl":"https://doi.org/10.1155/2014/761653","url":null,"abstract":"<p><p>Objective. Ultrasonographic characteristics are associated with thyroid malignancy. Our aim was to compare the diagnostic value of ultrasound features in the detection of thyroid malignancy in both solid and mixed nodules. Methods. We prospectively studied female patients (≥50 years) referred to ultrasound-guided fine needle aspiration biopsy. Ultrasound features considered suspicious were hypoechogenicity, microcalcifications, irregular margins, high anteroposterior (AP)/axial-ratio, and absent halo. Associations were separately assessed in mixed and solid nodules. Results. In a group of 504 elderly female patients (age = 69 ± 8 years), the frequency of malignant cytology was 6%. Thirty-one percent of nodules were mixed and 60% were solid. The rate of malignant cytology was similar for mixed and solid nodules (7.4 versus 5.8%, P: 0.56). While in mixed nodules none of the ultrasound characteristics were associated with malignant cytology, in solid nodules irregular margins and microcalcifications were significant (all P < 0.05). The combination of irregular margins and/or microcalcifications significantly increased the association with malignant cytology only in solid nodules (OR: 2.76 (95% CI: 1.25-6.10), P: 0.012). Conclusions. Ultrasound features were of poor diagnostic value in mixed nodules, which harbored malignant lesions as often as solid nodules. Our findings challenge the recommended minimal size for ultrasound-guided fine needle aspiration biopsy in mixed nodules. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2014 ","pages":"761653"},"PeriodicalIF":2.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/761653","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32524326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves' Disease Study. 巴塞杜氏病缓解诱导和维持研究》中208名患者的TSH受体自身免疫、甲状腺功能亢进、甲状腺肿和眼眶病之间的关系
IF 1.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2014-01-01 Epub Date: 2014-02-18 DOI: 10.1155/2014/165487
Peter Laurberg, Birte Nygaard, Stig Andersen, Allan Carlé, Jesper Karmisholt, Anne Krejbjerg, Inge Bülow Pedersen, Stine Linding Andersen

Background. Graves' disease may have a number of clinical manifestations with varying degrees of activity that may not always run in parallel. Objectives. To study associations between serum levels of TSH-receptor autoantibodies and the three main manifestations of Graves' disease (hyperthyroidism, goiter, and presence of orbitopathy) at the time of diagnosis of hyperthyroidism. Methods. We describe a cohort of 208 patients with newly diagnosed Graves' hyperthyroidism. Patients were enrolled in a multiphase study of antithyroid drug therapy of Graves' hyperthyroidism, entitled "Remission Induction and Sustenance in Graves' Disease (RISG)." Patients were systematically tested for degree of biochemical hyperthyroidism, enlarged thyroid volume by ultrasonography, and the presence of orbitopathy. Results. Positive correlations were found between the levels of TSH-receptor autoantibodies in serum and the three manifestations of Graves' disease: severeness of hyperthyroidism, presence of enlarged thyroid, and presence of orbitopathy, as well as between the different types of manifestations. Only around half of patients had enlarged thyroid gland at the time of diagnosis of hyperthyroidism, whereas 25-30% had orbitopathy. Conclusions. A positive but rather weak correlation was found between TSH-receptor antibodies in serum and the major clinical manifestation of Graves' disease. Only half of the patients had an enlarged thyroid gland at the time of diagnosis.

背景。巴塞杜氏病可能有多种临床表现,活动程度各不相同,而且不一定总是同时发生。研究目的研究确诊甲状腺功能亢进症时血清中 TSH 受体自身抗体水平与巴塞杜氏病三种主要表现(甲状腺功能亢进症、甲状腺肿和眼眶病)之间的关系。方法。我们对208名新确诊的巴塞杜氏甲亢患者进行了研究。患者参加了一项名为 "巴塞杜氏病缓解诱导与维持(RISG)"的多阶段巴塞杜氏甲亢抗甲状腺药物治疗研究。研究人员对患者的生化甲状腺功能亢进程度、超声波检查显示的甲状腺肿大程度以及是否存在眶病进行了系统检测。结果显示结果发现,血清中 TSH 受体自身抗体的水平与巴塞杜氏病的三种表现(甲状腺功能亢进的严重程度、甲状腺肿大和眼眶病)以及不同类型的表现之间存在正相关。只有约一半的患者在确诊甲状腺功能亢进症时有甲状腺肿大,而25%-30%的患者有眼眶病。结论是血清中的促甲状腺激素受体抗体与巴塞杜氏病的主要临床表现呈正相关,但相关性较弱。只有一半的患者在确诊时甲状腺肿大。
{"title":"Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves' Disease Study.","authors":"Peter Laurberg, Birte Nygaard, Stig Andersen, Allan Carlé, Jesper Karmisholt, Anne Krejbjerg, Inge Bülow Pedersen, Stine Linding Andersen","doi":"10.1155/2014/165487","DOIUrl":"10.1155/2014/165487","url":null,"abstract":"<p><p>Background. Graves' disease may have a number of clinical manifestations with varying degrees of activity that may not always run in parallel. Objectives. To study associations between serum levels of TSH-receptor autoantibodies and the three main manifestations of Graves' disease (hyperthyroidism, goiter, and presence of orbitopathy) at the time of diagnosis of hyperthyroidism. Methods. We describe a cohort of 208 patients with newly diagnosed Graves' hyperthyroidism. Patients were enrolled in a multiphase study of antithyroid drug therapy of Graves' hyperthyroidism, entitled \"Remission Induction and Sustenance in Graves' Disease (RISG).\" Patients were systematically tested for degree of biochemical hyperthyroidism, enlarged thyroid volume by ultrasonography, and the presence of orbitopathy. Results. Positive correlations were found between the levels of TSH-receptor autoantibodies in serum and the three manifestations of Graves' disease: severeness of hyperthyroidism, presence of enlarged thyroid, and presence of orbitopathy, as well as between the different types of manifestations. Only around half of patients had enlarged thyroid gland at the time of diagnosis of hyperthyroidism, whereas 25-30% had orbitopathy. Conclusions. A positive but rather weak correlation was found between TSH-receptor antibodies in serum and the major clinical manifestation of Graves' disease. Only half of the patients had an enlarged thyroid gland at the time of diagnosis. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2014 ","pages":"165487"},"PeriodicalIF":1.7,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32232657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
There is no elevation of immunoglobulin e levels in Albanian patients with autoimmune thyroid diseases. 阿尔巴尼亚自身免疫性甲状腺疾病患者的免疫球蛋白e水平没有升高。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2014-01-01 Epub Date: 2014-05-14 DOI: 10.1155/2014/283709
Hatixhe Latifi-Pupovci, Besa Gacaferri-Lumezi, Violeta Lokaj-Berisha

Background. Studies in several ethnic groups reported high incidence of elevated levels of immunoglobulin E (IgE) in patients with autoimmune thyroid diseases (ATD), especially in patients with Graves' disease. Objective. To study association between serum levels of IgE and thyroid stimulating hormone receptor antibodies (TRAb) in Albanian patients with ATD. Material and Methods. Study was performed in 40 patients with Graves' disease, 15 patients with Hashimoto's thyroiditis, and 14 subjects in the control group. The IgE levels were measured by immunoradiometric assay, whereas the TRAb levels were measured by radioreceptor assay. Results. In all groups of subjects the IgE levels were within reference values (<200 kIU/L). Significant difference in mean concentration of IgE was found between two groups of Graves' disease patients, and those with normal and elevated TRAb levels (22.57 versus 45.03, P < 0.05). Positive correlation was found between TRAb and IgE only in Graves' disease patients (r = 0.43, P = 0.006). Conclusion. In Albanian patients with ATD there is no elevation of IgE levels. This could be the result of low prevalence of allergic diseases in Albanian population determined by genetic and environmental factors.

背景。针对多个种族群体的研究报告显示,自身免疫性甲状腺疾病(ATD)患者,尤其是巴塞杜氏病患者中免疫球蛋白 E(IgE)水平升高的发生率很高。研究目的研究阿尔巴尼亚 ATD 患者血清中 IgE 水平与促甲状腺激素受体抗体(TRAb)之间的关系。材料与方法。研究对象包括40名巴塞杜氏病患者、15名桥本氏甲状腺炎患者和14名对照组受试者。IgE水平通过免疫放射测定法进行测量,而TRAb水平则通过放射受体测定法进行测量。结果显示所有组别的受试者的 IgE 水平都在参考值范围内(见图 1)。
{"title":"There is no elevation of immunoglobulin e levels in Albanian patients with autoimmune thyroid diseases.","authors":"Hatixhe Latifi-Pupovci, Besa Gacaferri-Lumezi, Violeta Lokaj-Berisha","doi":"10.1155/2014/283709","DOIUrl":"10.1155/2014/283709","url":null,"abstract":"<p><p>Background. Studies in several ethnic groups reported high incidence of elevated levels of immunoglobulin E (IgE) in patients with autoimmune thyroid diseases (ATD), especially in patients with Graves' disease. Objective. To study association between serum levels of IgE and thyroid stimulating hormone receptor antibodies (TRAb) in Albanian patients with ATD. Material and Methods. Study was performed in 40 patients with Graves' disease, 15 patients with Hashimoto's thyroiditis, and 14 subjects in the control group. The IgE levels were measured by immunoradiometric assay, whereas the TRAb levels were measured by radioreceptor assay. Results. In all groups of subjects the IgE levels were within reference values (<200 kIU/L). Significant difference in mean concentration of IgE was found between two groups of Graves' disease patients, and those with normal and elevated TRAb levels (22.57 versus 45.03, P < 0.05). Positive correlation was found between TRAb and IgE only in Graves' disease patients (r = 0.43, P = 0.006). Conclusion. In Albanian patients with ATD there is no elevation of IgE levels. This could be the result of low prevalence of allergic diseases in Albanian population determined by genetic and environmental factors. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2014 ","pages":"283709"},"PeriodicalIF":2.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32451427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro Study. 丙戊酸对甲状腺癌的有益作用是通过促进再分化和降低干细胞水平介导的:一项体外研究
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2014-01-01 Epub Date: 2014-05-15 DOI: 10.1155/2014/218763
Vahid Haghpanah, Mohsen Malehmir, Bagher Larijani, Shahin Ahmadian, Kamran Alimoghaddam, Ramin Heshmat, Ardeshir Ghavamzadeh, Khadijeh Adabi, Seyed H Ghaffari

Valproic acid (VPA) has been identified as a histone deacetylase inhibitor, inducing differentiation in transformed cells. However, no study has shown the effect of VPA in the redifferentiation induction and stemness of anaplastic thyroid. The main objective of this study was to evaluate the efficacy of VPA as a differentiation therapy agent in human thyroid cancer based on its effect on stemness and differentiation process. Indications for differentiation of 8305C and B-CPAP cell lines following VPA treatment were obtained by analyzing cell proliferation rate, morphological changes, adherent-dependent colony formation, and Hoechst 33342 staining. The expressions of stemness, differentiation, and aggressiveness specific marker genes were measured by quantitative RT-PCR. VPA treatment effectively showed growth inhibition in both cell lines. The high nuclear-cytoplasmic (N : C) ratio of 8305C cells markedly decreased and treated cells became more epithelial-like. Treated cells showed stronger Hoechst 33342 fluorescence compared with control cells. The hTERT and OCT-4 reduction was paralleled with adherent-dependent colony formation decrement in both cell lines. VPA effectively induced NIS and TTF-1 in anaplastic cells, it whereas showed no clear pattern in papillary cell line. VPA treatment also resulted in the reduction of MMP-2 and MMP-9. These finding suggest that VPA could redifferentiate the anaplastic thyroid cancer cells.

丙戊酸(VPA)是一种组蛋白去乙酰化酶抑制剂,可诱导转化细胞分化。然而,没有研究显示VPA在间变性甲状腺的再分化诱导和干性中的作用。本研究的主要目的是基于VPA对人甲状腺癌干细胞和分化过程的影响,评价其作为分化治疗剂对人甲状腺癌的疗效。通过分析VPA处理后8305C和B-CPAP细胞株的增殖率、形态变化、贴壁依赖性菌落形成及Hoechst 33342染色,获得VPA处理后8305C和B-CPAP细胞株的分化适应症。采用定量RT-PCR法检测干性、分化性和侵袭性特异性标记基因的表达。VPA处理有效抑制了两种细胞系的生长。8305C细胞的高核质比(N: C)明显降低,处理后的细胞更接近上皮样。与对照细胞相比,处理细胞显示出更强的Hoechst 33342荧光。在两种细胞系中,hTERT和OCT-4的减少与粘附依赖性集落形成的减少是平行的。VPA对间变性细胞有诱导NIS和TTF-1的作用,而对乳头状细胞系无明显的诱导作用。VPA处理也导致MMP-2和MMP-9的减少。提示VPA对甲状腺间变性癌细胞具有再分化作用。
{"title":"The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro Study.","authors":"Vahid Haghpanah,&nbsp;Mohsen Malehmir,&nbsp;Bagher Larijani,&nbsp;Shahin Ahmadian,&nbsp;Kamran Alimoghaddam,&nbsp;Ramin Heshmat,&nbsp;Ardeshir Ghavamzadeh,&nbsp;Khadijeh Adabi,&nbsp;Seyed H Ghaffari","doi":"10.1155/2014/218763","DOIUrl":"https://doi.org/10.1155/2014/218763","url":null,"abstract":"<p><p>Valproic acid (VPA) has been identified as a histone deacetylase inhibitor, inducing differentiation in transformed cells. However, no study has shown the effect of VPA in the redifferentiation induction and stemness of anaplastic thyroid. The main objective of this study was to evaluate the efficacy of VPA as a differentiation therapy agent in human thyroid cancer based on its effect on stemness and differentiation process. Indications for differentiation of 8305C and B-CPAP cell lines following VPA treatment were obtained by analyzing cell proliferation rate, morphological changes, adherent-dependent colony formation, and Hoechst 33342 staining. The expressions of stemness, differentiation, and aggressiveness specific marker genes were measured by quantitative RT-PCR. VPA treatment effectively showed growth inhibition in both cell lines. The high nuclear-cytoplasmic (N : C) ratio of 8305C cells markedly decreased and treated cells became more epithelial-like. Treated cells showed stronger Hoechst 33342 fluorescence compared with control cells. The hTERT and OCT-4 reduction was paralleled with adherent-dependent colony formation decrement in both cell lines. VPA effectively induced NIS and TTF-1 in anaplastic cells, it whereas showed no clear pattern in papillary cell line. VPA treatment also resulted in the reduction of MMP-2 and MMP-9. These finding suggest that VPA could redifferentiate the anaplastic thyroid cancer cells. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2014 ","pages":"218763"},"PeriodicalIF":2.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/218763","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32454765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Symptoms and signs associated with postpartum thyroiditis. 产后甲状腺炎的相关症状和体征。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2014-01-01 Epub Date: 2014-10-27 DOI: 10.1155/2014/531969
Maureen Groer, Cecilia Jevitt
Background. Postpartum thyroiditis (PPT) is a common triphasic autoimmune disease in women with thyroid peroxidase (TPO) autoantibodies. This study evaluated women's thyroid disease symptoms, physical findings, stress levels, and thyroid stimulating hormone (TSH) levels across six postpartum months in three groups, TPO negative, TPO positive, and PPT positive women. Methods. Women were recruited in midpregnancy (n = 631) and TPO status was determined which then was used to form the three postpartum groups. The three groups were compared on TSH levels, thyroid symptoms, weight, blood pressure, heart rate, a thyroid exam, and stress scores. Results. Fifty-six percent of the TPO positive women developed PPT. Hypothyroid group (F (2, 742) = 5.8, P = .003) and hyperthyroid group (F (2, 747) = 6.6, P = .001) subscale scores differed by group. Several symptoms and stress scores were highest in the PPT group. Conclusions. The normal postpartum is associated with many symptoms that mimic thyroid disease symptoms, but severity is greater in women with either TPO or PPT positivity. While the most severe symptoms were generally seen in PPT positive women, even TPO positive women seem to have higher risk for these signs and symptoms.
背景。产后甲状腺炎(PPT)是甲状腺过氧化物酶(TPO)自身抗体妇女常见的三期自身免疫性疾病。本研究评估了三组(TPO阴性、TPO阳性和PPT阳性)妇女产后6个月的甲状腺疾病症状、身体检查结果、压力水平和促甲状腺激素(TSH)水平。方法。在怀孕中期招募妇女(n = 631),并确定TPO状态,然后用于组成三个产后组。比较三组的TSH水平、甲状腺症状、体重、血压、心率、甲状腺检查和压力评分。结果。TPO阳性的女性中有56%患有PPT。甲状腺功能减退组(F (2,742) = 5.8, P = 0.003)和甲状腺功能亢进组(F (2,747) = 6.6, P = 0.001)亚量表评分组间存在差异。PPT组的一些症状和压力得分最高。结论。正常的产后有许多类似甲状腺疾病的症状,但在TPO或PPT阳性的妇女中,严重程度更大。虽然最严重的症状通常出现在PPT阳性的女性身上,但即使是TPO阳性的女性似乎也有更高的风险出现这些症状和体征。
{"title":"Symptoms and signs associated with postpartum thyroiditis.","authors":"Maureen Groer,&nbsp;Cecilia Jevitt","doi":"10.1155/2014/531969","DOIUrl":"https://doi.org/10.1155/2014/531969","url":null,"abstract":"Background. Postpartum thyroiditis (PPT) is a common triphasic autoimmune disease in women with thyroid peroxidase (TPO) autoantibodies. This study evaluated women's thyroid disease symptoms, physical findings, stress levels, and thyroid stimulating hormone (TSH) levels across six postpartum months in three groups, TPO negative, TPO positive, and PPT positive women. Methods. Women were recruited in midpregnancy (n = 631) and TPO status was determined which then was used to form the three postpartum groups. The three groups were compared on TSH levels, thyroid symptoms, weight, blood pressure, heart rate, a thyroid exam, and stress scores. Results. Fifty-six percent of the TPO positive women developed PPT. Hypothyroid group (F (2, 742) = 5.8, P = .003) and hyperthyroid group (F (2, 747) = 6.6, P = .001) subscale scores differed by group. Several symptoms and stress scores were highest in the PPT group. Conclusions. The normal postpartum is associated with many symptoms that mimic thyroid disease symptoms, but severity is greater in women with either TPO or PPT positivity. While the most severe symptoms were generally seen in PPT positive women, even TPO positive women seem to have higher risk for these signs and symptoms.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2014 ","pages":"531969"},"PeriodicalIF":2.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/531969","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32821758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Urinary Iodine Clearance following Iodinated Contrast Administration: A Comparison of Euthyroid and Postthyroidectomy Subjects. 碘造影剂给药后尿碘清除率:甲状腺功能正常和甲状腺切除术后受试者的比较。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2014-01-01 Epub Date: 2014-11-12 DOI: 10.1155/2014/580569
Janice D Ho, James F Tsang, Kylie A Scoggan, William D Leslie

Purpose. To compare iodine clearance following iodinated contrast administration in thyroidectomised thyroid cancer patients and euthyroid individuals. Methods. A convenience population (6 thyroidectomised thyroid cancer patients and 7 euthyroid controls) was drawn from patients referred for iodinated contrast-enhanced computed tomography (CT) studies. Subjects had sequential urine samples collected up to 6 months (50 samples from the thyroidectomised and 63 samples from the euthyroid groups). t-tests and generalised estimating equations (GEE) were used to test for group differences in urinary iodine creatinine ratios. Results. Groups had similar urinary iodine creatinine ratios at baseline, with a large increase 2 weeks following iodinated contrast (P = 0.005). Both groups had a return of urinary iodine creatinine ratios to baseline by 4 weeks, with no significant group differences overall or at any time point. Conclusions. Thyroidectomised patients did not have a significantly different urinary iodine clearance than euthyroid individuals following administration of iodinated contrast. Both had a return of urinary iodine creatinine ratios to baseline within 4 weeks.

目的。比较甲状腺癌切除患者和甲状腺功能正常个体碘造影剂使用后的碘清除率。方法。方便人群(6名甲状腺癌切除术患者和7名甲状腺正常对照)从接受碘化对比增强计算机断层扫描(CT)研究的患者中抽取。受试者连续收集了6个月的尿液样本(50份来自甲状腺切除术组,63份来自甲状腺功能正常组)。采用t检验和广义估计方程(GEE)来检验尿碘肌酐比值的组间差异。结果。各组在基线时尿碘肌酐比值相似,碘化对比2周后显著升高(P = 0.005)。两组的尿碘肌酐比在4周后恢复到基线水平,总体上或在任何时间点上没有明显的组间差异。结论。甲状腺切除术患者在给予碘造影剂后,尿碘清除率与甲状腺功能正常的患者没有显著差异。两人均在4周内尿碘肌酐恢复到基线水平。
{"title":"Urinary Iodine Clearance following Iodinated Contrast Administration: A Comparison of Euthyroid and Postthyroidectomy Subjects.","authors":"Janice D Ho,&nbsp;James F Tsang,&nbsp;Kylie A Scoggan,&nbsp;William D Leslie","doi":"10.1155/2014/580569","DOIUrl":"https://doi.org/10.1155/2014/580569","url":null,"abstract":"<p><p>Purpose. To compare iodine clearance following iodinated contrast administration in thyroidectomised thyroid cancer patients and euthyroid individuals. Methods. A convenience population (6 thyroidectomised thyroid cancer patients and 7 euthyroid controls) was drawn from patients referred for iodinated contrast-enhanced computed tomography (CT) studies. Subjects had sequential urine samples collected up to 6 months (50 samples from the thyroidectomised and 63 samples from the euthyroid groups). t-tests and generalised estimating equations (GEE) were used to test for group differences in urinary iodine creatinine ratios. Results. Groups had similar urinary iodine creatinine ratios at baseline, with a large increase 2 weeks following iodinated contrast (P = 0.005). Both groups had a return of urinary iodine creatinine ratios to baseline by 4 weeks, with no significant group differences overall or at any time point. Conclusions. Thyroidectomised patients did not have a significantly different urinary iodine clearance than euthyroid individuals following administration of iodinated contrast. Both had a return of urinary iodine creatinine ratios to baseline within 4 weeks. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2014 ","pages":"580569"},"PeriodicalIF":2.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/580569","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32882674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
期刊
Journal of Thyroid Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1